Redpin Therapeutics | 4biocapital

NEWSROOM

Nov 16, 2022

4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics

Mar 25, 2020

4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A